AIDS
- MANGAL TD, Chimpandule T, Bhatia S, Molaro M, et al
Health, workforce, and cost trade-offs of HIV programme prioritization strategies
in Malawi.
AIDS. 2026 Oct 23. doi: 10.1097/QAD.0000000000004643.
- BUZON-MARTIN L, Cabello-Clotet N, Gea-Grela A, Cuevas G, et al
Controlled adherence with long-acting injectable cabotegravir plus rilpivirine:
determinants and clinical impact of injection-schedule adherence in the Spanish
RELATIVITY cohort.
AIDS. 2026 Oct 23. doi: 10.1097/QAD.0000000000004629.
Clin Infect Dis
- TRAINOR BW, Osborn JL, Klausner JD, Satlin MJ, et al
Enabling Ciprofloxacin Resistance-Guided Therapy for Neisseria gonorrhoeae:
Aligning Diagnostics, Regulation, Guidelines, and Reimbursement.
Clin Infect Dis. 2026 Oct 22:ciag640. doi: 10.1093.
- WANG C, Rivera AE, Kleiner DE, Ma CA, et al
Disseminated Nontuberculous Mycobacterial Disease in NEMO and Ikappabalpha Defects.
Clin Infect Dis. 2026 Oct 22:ciag602. doi: 10.1093.
- RAMASWAMI R, Suneja G
Beyond Viral Suppression: Persistent HPV-Associated Cancer Risk in People With
HIV.
Clin Infect Dis. 2026 Oct 22:ciag502. doi: 10.1093.
- SINGH UB, DiBona K, Shaikh S, Mattoo SK, et al
Not All Extrapulmonary Tuberculosis Is Equal: Site-Specific Mortality in a
National Indian Cohort.
Clin Infect Dis. 2026 Oct 19:ciag677. doi: 10.1093.
HIV Med
- CONNOLLY SP, Carey C, Lenihan C, McFaul K, et al
A retrospective cohort study of Ukrainian beneficiaries of temporary protection
living with HIV attending an Irish tertiary care service.
HIV Med. 2026 Oct 16. doi: 10.1111/hiv.70328.
- HU M, Wang Z, Zhang J, Li X, et al
Information quality, understandability, actionability and readability of large
language models for HIV health education: A cross-platform evaluation.
HIV Med. 2026 Oct 18. doi: 10.1111/hiv.70329.
- LANG R, Humes E, Lyass A, Borowsky LH, et al
Changes in cardiometabolic biomarkers 1 year after direct acting antiviral
therapy for hepatitis C virus co-infection among people with HIV.
HIV Med. 2026 Oct 18. doi: 10.1111/hiv.70325.
- KOH MCY, Ngiam JN, Yong HYJ, Puspita T, et al
Pilot study of a ChatGPT-based educational and counselling tool in a specialist
HIV and sexual health clinic.
HIV Med. 2026 Oct 18. doi: 10.1111/hiv.70323.
- MAGATI RB, Njiro BJ, Ntissi HH, Manguzu MA, et al
Antiretroviral therapy intensification in people living with HIV on virological
and clinical outcomes: A systematic review.
HIV Med. 2026 Oct 18. doi: 10.1111/hiv.70333.
- VINCENT-PAULRAJ A, Wood W, Marzolini C, Chiong J, et al
Understanding community questions about HIV pre-exposure prophylaxis (PrEP): A
thematic analysis of reddit threads to inform development of an AI chatbot for
PrEP education.
HIV Med. 2026 Oct 20. doi: 10.1111/hiv.70332.
- ALEKSEEVA I, Woods N, Savary-Trathen A, Norcross C, et al
Baseline HIV genotypic resistance testing in patients newly diagnosed with HIV:
When do we need to consider baseline integrase resistance testing for everyone?
HIV Med. 2026 Oct 22. doi: 10.1111/hiv.70334.
- DE VEGA M, Benson AC, Martin-Iguacel R, Torres B, et al
Sex- and migration-related differences in viral suppression and life expectancy
among people with HIV: The PISCIS cohort, 1998-2023.
HIV Med. 2026 Oct 22. doi: 10.1111/hiv.70326.
Int J Dermatol
- KELLY SH, Lowe S, Walker SL, Bernays S, et al
Addressing the Geographic Reporting Bias in HIV-Associated Acquired
Epidermodysplasia Verruciformis.
Int J Dermatol. 2026 Oct 20. doi: 10.1111/ijd.70741.
J Acquir Immune Defic Syndr
- NALINTYA E, Poeschla A, Fieberg A, Nerima P, et al
Birth and clinical outcomes of pregnant participants with advanced HIV disease.
J Acquir Immune Defic Syndr. 2026 Oct 20. doi: 10.1097/QAI.0000000000003995.
- VAN DER WEKKEN-PAS L, Pajkrt D, Burger D, Hessing F, et al
Infant exposure to antiretroviral drugs and HIV RNA in breastmilk of women living
with HIV.
J Acquir Immune Defic Syndr. 2026 Oct 20. doi: 10.1097/QAI.0000000000003991.
J Am Acad Dermatol
- KARPOFF K, Pasumarthi A, Lebwohl M
Psoriasis: Which therapy for which patient, updated, part II. Focus on special
populations and chronic infections.
J Am Acad Dermatol. 2026 Oct 22:S0190-9622(26)03755.
J Immunol
- MARENCO A, Varco-Merth B, Nkoy C, Govindan A, et al
Preservation of MHC-Ia protective allele suppression of SIVmac239 in aged rhesus
macaques.
J Immunol. 2026;215:vkag272.
J Infect Dis
- SESAY FA, Balkus JE, Jaoko W, Mureithi M, et al
Association Between Vaginal Gram Stain Categories and Cervicitis in Kenyan Women
Who Engage in Sex Work.
J Infect Dis. 2026 Oct 17:jiag519. doi: 10.1093.
- THOREAU B, Renaud A, Chafey P, Clary G, et al
Anti-annexin A5 Autoantibodies in Pulmonary Arterial Hypertension Related to
Human Immunodeficiency Virus Infection (HIV-PAH): A Case-Control Study.
J Infect Dis. 2026 Oct 21:jiag470. doi: 10.1093.
J Med Virol
- LEE SS, Chan DP, Wong BC, Cheung DKF, et al
Resurgence of Sexually Transmitted Hepatitis C Virus Infection in Men Who Have
Sex With Men Living With HIV.
J Med Virol. 2026;98:e71185.
Lancet Infect Dis
- POLLOCK KM, Saunders JE, Fowler J, Camara S, et al
Safety and immunogenicity of an adenoviral-vectored vaccine against Crimean-Congo
haemorrhagic fever in the UK (CCHF01): an open-label, first-in-human,
non-randomised, phase 1 clinical trial.
Lancet Infect Dis. 2026 Oct 23:S1473-3099(26)00471.
Nat Med
- MOSSER JF, Liu J
Global, regional and national burden of pertussis in 1990-2023: a Global Burden
of Disease study.
Nat Med. 2026 Oct 21. doi: 10.1038/s41591-026-04660.
PLoS Med
- GRAD YH, Mittelstaedt R, Peters RPH
How do we monitor doxy-PEP impact and when should we consider revisiting
guidelines?
PLoS Med. 2026;23:e1005276.
- DAWE J, Mazhar KA, Khan SA, Njiro BJ, et al
Impact of violence on HIV outcomes among female sex workers: A global systematic
review and meta-analysis.
PLoS Med. 2026;23:e1004977.
PLoS One
- ALEMU GG, Bazezew AM, Yirsaw AN, Wondie WT, et al
Precancerous cervical lesions and associated factors among HIV-positive women in
Southern and Eastern African countries: A systematic review and meta-analysis.
PLoS One. 2026;21:e0361185.
- SANYA N, Vaccaro ME, Uppal M, Glen S, et al
PREnatal Syphilis point-of-care ScreenING in an urban low-barrier clinic
(PRESSING) study: Protocol for a prospective single arm feasibility trial.
PLoS One. 2026;21:e0360150.
- GEREZGIHER GG, Gebreslassie T, Woldemariam GT, Tesfamicale YA, et al
Incidence and predictors of mother-to-child transmission of HIV among HIV-exposed
infants in public General hospitals of Tigray, Ethiopia, 2020: Retrospective
cohort study.
PLoS One. 2026;21:e0358878.
- PALAMOUNTAIN KM, Achar C, Kirby RP, Manabe YC, et al
Global stakeholder preferences for point-of-care HIV nucleic acid amplification
tests: A conjoint study.
PLoS One. 2026;21:e0361025.
PLoS Pathog
- YAN S, Durringer A, Woottum M, Benichou S, et al
HIV-1 cell-to-cell infection of macrophages escapes restriction by the BST-2 host
cell factor independently of the Vpu counteracting viral protein.
PLoS Pathog. 2026;22:e1014702.
- BODYKEVICH EG, Castello Casta F, Flynn JK, Nichols CA, et al
Oral uracil treatment increases susceptibility to rectal SIV infection.
PLoS Pathog. 2026;22:e1014716.
- HAMANN MV, Brauckmann L, Schwarz C, Spohn M, et al
Selective persistence of HIV-1-infected T cell clones can occur through immune
reprogramming driven by defective, transcriptionally active proviruses.
PLoS Pathog. 2026;22:e1014618.
Proc Natl Acad Sci U S A
- GHOSH K, Gupta M, Voth GA
Mechanism of HIV-1 capsid rupture and uncoating by reverse transcription.
Proc Natl Acad Sci U S A. 2026;123:e2617714123.
- BROWN AW, Al-Izzi SC, Parker JL, Hertel S, et al
Capillary physics links HIV capsid geometry to nuclear pore translocation.
Proc Natl Acad Sci U S A. 2026;123:e2605059123.
Virology
- ZHANG X, Li A, Zheng R, Zhang L, et al
The role of autocrine motility factor receptor in antiviral immunity.
Virology. 2026;625:111100.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016